Creative Planning’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Creative Planning’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-497	Closed	-$35K	–	2460
2021 Q4	$35K	Buy	+497	New	+$41.9K	﹤0.01%	2018
2021 Q2	–	Sell	-9,736	Closed	-$908K	–	2657
2021 Q1	$908K	Sell	9,736 -2,000	-17%	-$203K	﹤0.01%	1077
2020 Q4	$968K	Buy	11,736 +10,645	+976%	+$908K	﹤0.01%	970
2020 Q3	$94K	Sell	1,091 -6,984	-86%	-$814K	﹤0.01%	1834
2020 Q2	$751K	Buy	8,075 +5,238	+185%	+$289K	﹤0.01%	850
2020 Q1	$81K	Buy	2,837 +2,270	+400%	+$88.2K	﹤0.01%	1568
2019 Q4	$23K	Buy	+567	New	+$12.4K	﹤0.01%	1870

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Creative Planning's VBIV Position: Q1 2022 in Review

Creative Planning sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2022, closing a stake of 497 shares — an estimated $35K sold.

Creative Planning first reported a position in VBIV in Q4 2019 and held it in 7 quarters. The position peaked at $968K in Q4 2020. 131 funds tracked by Wall St. Rank hold VBIV as of Q1 2022.

Creative Planning reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2022 after selling out during the quarter.
Creative Planning sold 497 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2022, an estimated $35K.
Creative Planning first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2019 and held it in 7 quarters.
Creative Planning's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $968K in Q4 2020.
131 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2022.

Based on Creative Planning's 13F filing for Q1 2022, filed 16 May 2022.